Squarepoint’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36M | Buy |
84,919
+74,494
| +715% | +$1.19M | ﹤0.01% | 1350 |
|
|
2025
Q1 | $178K | Buy |
+10,425
| New | +$178K | ﹤0.01% | 2396 |
|
|
2024
Q3 | – | Sell |
-49,288
| Closed | -$1.3M | – | 2752 |
|
|
2024
Q2 | $1.3M | Buy |
49,288
+2,615
| +6% | +$69K | ﹤0.01% | 1248 |
|
|
2024
Q1 | $1.51M | Buy |
+46,673
| New | +$1.51M | ﹤0.01% | 1162 |
|
|
2023
Q4 | – | Sell |
-14,587
| Closed | -$560K | – | 2718 |
|
|
2023
Q3 | $560K | Buy |
+14,587
| New | +$560K | ﹤0.01% | 1573 |
|
|
2023
Q2 | – | Sell |
-93,895
| Closed | -$1.46M | – | 2600 |
|
|
2023
Q1 | $1.46M | Buy |
93,895
+58,943
| +169% | +$914K | 0.01% | 980 |
|
|
2022
Q4 | $620K | Buy |
+34,952
| New | +$620K | ﹤0.01% | 1351 |
|
|
2022
Q2 | – | Sell |
-28,037
| Closed | -$154K | – | 2351 |
|
|
2022
Q1 | $154K | Sell |
28,037
-39,879
| -59% | -$219K | ﹤0.01% | 1967 |
|
|
2021
Q4 | $579K | Sell |
67,916
-10,364
| -13% | -$88.4K | ﹤0.01% | 1516 |
|
|
2021
Q3 | $680K | Buy |
78,280
+42,874
| +121% | +$372K | ﹤0.01% | 1244 |
|
|
2021
Q2 | $374K | Sell |
35,406
-11,439
| -24% | -$121K | ﹤0.01% | 1806 |
|
|
2021
Q1 | $751K | Buy |
46,845
+24,458
| +109% | +$392K | ﹤0.01% | 1274 |
|
|
2020
Q4 | $1.03M | Buy |
22,387
+4,777
| +27% | +$221K | 0.01% | 1058 |
|
|
2020
Q3 | $620K | Buy |
+17,610
| New | +$620K | 0.01% | 1190 |
|